Literature DB >> 19643403

Understanding adenomyosis: a case control study.

F Andrei Taran1, Amy L Weaver2, Charles C Coddington1, Elizabeth A Stewart3.   

Abstract

OBJECTIVE: To elucidate the clinical profile of adenomyosis by comparison with uterine leiomyomas.
DESIGN: Retrospective case-control study.
SETTING: Academic medical center. PATIENT(S): The study comprised 76 women undergoing hysterectomy with adenomyosis and 152 women with uterine leiomyomas but no adenomyosis. INTERVENTION(S): Retrospective medical record review of hospital and ambulatory records. MAIN OUTCOME MEASURE(S): Comparison of women undergoing hysterectomy with a sole pathologic finding of adenomyosis and women with leiomyomas alone. RESULT(S): Adenomyosis was independently associated with younger age (41.1 years vs. 44.3 years), history of depression (57.1% vs. 24.7%), dysmenorrhea (65.7% vs. 42.3%), and pelvic pain (52.9% vs. 21.1%) in a multivariable unconditional logistic regression analysis compared with women with leiomyomas, where women from both groups had gynecologic symptoms. Furthermore, in a second multivariate model where all subjects had uteri weighing>150 g, women with adenomyosis were more likely to have a history of depression (52.6% vs. 22.2%) and endometriosis (26.3% vs. 2.8%) compared with women with leiomyomas. CONCLUSION(S): Women undergoing hysterectomy with a histologic diagnosis of adenomyosis have a distinct symptomatology and medical history compared with women with leiomyomas. Better understanding of this disease is required to improve diagnosis and management. Copyright (c) 2010. Published by Elsevier Inc.

Entities:  

Mesh:

Year:  2009        PMID: 19643403      PMCID: PMC3150965          DOI: 10.1016/j.fertnstert.2009.06.049

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  33 in total

Review 1.  Uterine fibroids: the elephant in the room.

Authors:  Cheryl Lyn Walker; Elizabeth A Stewart
Journal:  Science       Date:  2005-06-10       Impact factor: 47.728

2.  In situ detection of prolactin receptor mRNA and apoptotic cell death in mouse uterine tissues with adenomyosis.

Authors:  M Yamashita; M Matsuda; T Mori
Journal:  In Vivo       Date:  1999 Jan-Feb       Impact factor: 2.155

3.  The meaning and use of the area under a receiver operating characteristic (ROC) curve.

Authors:  J A Hanley; B J McNeil
Journal:  Radiology       Date:  1982-04       Impact factor: 11.105

4.  Adenomyosis demonstrates increased expression of the basic fibroblast growth factor receptor/ligand system compared with autologous endometrium.

Authors:  A M Propst; B J Quade; A R Gargiulo; R A Nowak; E A Stewart
Journal:  Menopause       Date:  2001 Sep-Oct       Impact factor: 2.953

5.  Midterm results of uterine artery embolization for symptomatic adenomyosis: initial experience.

Authors:  Jean-Pierre Pelage; Denis Jacob; Afchine Fazel; Julien Namur; Alexandre Laurent; Roland Rymer; Olivier Le Dref
Journal:  Radiology       Date:  2005-01-28       Impact factor: 11.105

Review 6.  Uterine fibroids.

Authors:  E A Stewart
Journal:  Lancet       Date:  2001-01-27       Impact factor: 79.321

7.  Is prior uterine surgery a risk factor for adenomyosis?

Authors:  Uma R Panganamamula; Ozgur H Harmanli; Ebru F Isik-Akbay; Chad A Grotegut; Vani Dandolu; John P Gaughan
Journal:  Obstet Gynecol       Date:  2004-11       Impact factor: 7.661

8.  Successful use of magnetic resonance-guided focused ultrasound surgery to relieve symptoms in a patient with symptomatic focal adenomyosis.

Authors:  Sang-Wook Yoon; Kyoung Ah Kim; Sun Hee Cha; Yong Min Kim; Chan Lee; Young-Jeong Na; Seung-Jo Kim
Journal:  Fertil Steril       Date:  2008-08-09       Impact factor: 7.329

9.  A murine model of adenomyosis: the effects of hyperprolactinemia induced by fluoxetine hydrochloride, a selective serotonin reuptake inhibitor, on adenomyosis induction in Wistar albino rats.

Authors:  C Fiçicioğlu; H I Tekin; P F Arioğlu; I Okar
Journal:  Acta Eur Fertil       Date:  1995 Mar-Apr

10.  The association between endometriosis and spontaneous abortion. A retrospective clinical study.

Authors:  D L Olive; R R Franklin; L V Gratkins
Journal:  J Reprod Med       Date:  1982-06       Impact factor: 0.142

View more
  12 in total

1.  Characteristics indicating adenomyosis coexisting with leiomyomas: a case-control study.

Authors:  F Andrei Taran; Amy L Weaver; Charles C Coddington; Elizabeth A Stewart
Journal:  Hum Reprod       Date:  2010-02-22       Impact factor: 6.918

2.  Perioperative Suppression of Schwann Cell Dedifferentiation Reduces the Risk of Adenomyosis Resulting from Endometrial-Myometrial Interface Disruption in Mice.

Authors:  Xi Wang; Xishi Liu; Sun-Wei Guo
Journal:  Biomedicines       Date:  2022-05-24

3.  Establishment of a novel mouse model of adenomyosis suitable for longitudinal and quantitative analysis and perinatal outcome studies.

Authors:  Mohammed Elsherbini; Kaori Koga; Takehiro Hiraoka; Keiichi Kumasawa; Eiko Maki; Erina Satake; Ayumi Taguchi; Tomoko Makabe; Arisa Takeuchi; Gentaro Izumi; Masashi Takamura; Miyuki Harada; Tetsuya Hirata; Yasushi Hirota; Osamu Wada-Hiraike; Yutaka Osuga
Journal:  Sci Rep       Date:  2022-10-20       Impact factor: 4.996

4.  Adenomyosis: Epidemiology, Risk Factors, Clinical Phenotype and Surgical and Interventional Alternatives to Hysterectomy.

Authors:  F A Taran; E A Stewart; S Brucker
Journal:  Geburtshilfe Frauenheilkd       Date:  2013-09       Impact factor: 2.915

Review 5.  Myomas and Adenomyosis: Impact on Reproductive Outcome.

Authors:  Nikos F Vlahos; Theodoros D Theodoridis; George A Partsinevelos
Journal:  Biomed Res Int       Date:  2017-11-06       Impact factor: 3.411

6.  Effects of Etonogestrel implants on pelvic pain and menstrual flow in women suffering from adenomyosis or endometriosis: Results from a prospective, observational study.

Authors:  Xiaocen Niu; Qun Luo; Chunfen Wang; Lihua Zhu; Lili Huang
Journal:  Medicine (Baltimore)       Date:  2021-02-12       Impact factor: 1.817

7.  Characterization of patients that can continue conservative treatment for adenomyosis.

Authors:  Chiho Miyagawa; Kosuke Murakami; Takako Tobiume; Takafumi Nonogaki; Noriomi Matsumura
Journal:  BMC Womens Health       Date:  2021-12-28       Impact factor: 2.809

8.  Efficacy and safety of elagolix with add-back therapy in women with uterine fibroids and coexisting adenomyosis.

Authors:  Ozgul Muneyyirci-Delale; David F Archer; Charlotte D Owens; Kurt T Barnhart; Linda D Bradley; Eve Feinberg; Veronica Gillispie; Sandra Hurtado; Jin Hee Kim; Alice Wang; Hui Wang; Elizabeth A Stewart
Journal:  F S Rep       Date:  2021-05-26

9.  Sonographic Signs of Adenomyosis in Women with Endometriosis Are Associated with Infertility.

Authors:  Dean Decter; Nissim Arbib; Hila Markovitz; Daniel S Seidman; Vered H Eisenberg
Journal:  J Clin Med       Date:  2021-05-27       Impact factor: 4.241

10.  The Significance of MRI Evaluation of the Uterine Junctional Zone in the Early Diagnosis of Adenomyosis.

Authors:  Amela Sofic; Azra Husic-Selimovic; Aladin Carovac; Elma Jahic; Velda Smailbegovic; Jana Kupusovic
Journal:  Acta Inform Med       Date:  2016-03-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.